The Role of Mutations on HLA Genes in Lambert-Eaton Myasthenic Syndrome
Keyword(s):
Lambert-Eaton myasthenic syndrome (LEMS) is a rare presynaptic disorder of neuromuscular transmission in which quantal release of acetylcholine (ACh) is impaired, causing a unique set of clinical characteristics, which include proximal muscle weakness, depressed tendon reflexes, posttetanic potentiation, and autonomic changes. [1] The initial presentation can be similar to that of myasthenia gravis (MG), but the progressions of the 2 diseases have some important differences. LEMS disrupts the normally reliable neurotransmission at the neuromuscular junction (NMJ). This disruption is thought to result from an autoantibody-mediated removal of a subset of the P/Q-type Ca2+ channels involved with neurotransmitter release.
1993 ◽
Vol 87
(1)
◽
pp. 3-14
◽
Keyword(s):
2021 ◽
2002 ◽
Vol 72
(1-2)
◽
pp. 93-99
◽
1988 ◽
Vol 255
(4)
◽
pp. E469-E474
Keyword(s):